Evelyn Partners Investment Management (Europe)’s Thermo Fisher Scientific TMO Stock Holding History

Evelyn Partners Investment Management (Europe)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.31M	Sell	2,662 -85	-3%	-$46.1K	0.45%	43
2025 Q4	$1.59M	Buy	2,747 +384	+16%	+$217K	0.52%	41
2025 Q3	$1.15M	Sell	2,363 -115	-5%	-$53.5K	0.4%	42
2025 Q2	$1M	Sell	2,478 -345	-12%	-$144K	0.36%	46
2025 Q1	$1.4M	Buy	2,823 +806	+40%	+$437K	0.53%	39
2024 Q4	$1.05M	Buy	+2,017	New	+$1.11M	0.38%	46

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Evelyn Partners Investment Management (Europe)'s TMO Position: Q1 2026 in Review

Evelyn Partners Investment Management (Europe) reduced its Thermo Fisher Scientific (TMO) stake by 3.1% in Q1 2026, selling an estimated $46.1K and leaving 2,662 shares worth $1.31M. The position accounts for 0.45% of the portfolio, ranked #43.

Evelyn Partners Investment Management (Europe) first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.59M in Q4 2025. 2,596 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Evelyn Partners Investment Management (Europe) held 2,662 shares of Thermo Fisher Scientific worth $1.31M as of Q1 2026.
Evelyn Partners Investment Management (Europe) sold 85 Thermo Fisher Scientific shares in Q1 2026, an estimated $46.1K.
Thermo Fisher Scientific made up 0.45% of Evelyn Partners Investment Management (Europe)'s portfolio in Q1 2026, its #43 holding.
Evelyn Partners Investment Management (Europe) first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
Evelyn Partners Investment Management (Europe)'s Thermo Fisher Scientific position peaked at $1.59M in Q4 2025.
2,596 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Evelyn Partners Investment Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.